These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 9416840)

  • 1. Rel/NF-kappa B transcription factors and I kappa B inhibitors: evolution from a unique common ancestor.
    Huguet C; Crepieux P; Laudet V
    Oncogene; 1997 Dec; 15(24):2965-74. PubMed ID: 9416840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. I kappa B epsilon, a novel member of the I kappa B family, controls RelA and cRel NF-kappa B activity.
    Whiteside ST; Epinat JC; Rice NR; Israël A
    EMBO J; 1997 Mar; 16(6):1413-26. PubMed ID: 9135156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Candidate proto-oncogene bcl-3 encodes a subunit-specific inhibitor of transcription factor NF-kappa B.
    Wulczyn FG; Naumann M; Scheidereit C
    Nature; 1992 Aug; 358(6387):597-9. PubMed ID: 1501714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rel/NF-kappa B and I kappa B proteins: an overview.
    May MJ; Ghosh S
    Semin Cancer Biol; 1997 Apr; 8(2):63-73. PubMed ID: 9299584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rel/NF-kappa B and I kappa B factors in oncogenesis.
    Luque I; Gélinas C
    Semin Cancer Biol; 1997 Apr; 8(2):103-11. PubMed ID: 9299588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic approaches to study Rel/NF-kappa B/I kappa B function in mice.
    Attar RM; Caamaño J; Carrasco D; Iotsova V; Ishikawa H; Ryseck RP; Weih F; Bravo R
    Semin Cancer Biol; 1997 Apr; 8(2):93-101. PubMed ID: 9299587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Divergent C-terminal transactivation domains of Rel/NF-kappa B proteins are critical determinants of their oncogenic potential in lymphocytes.
    Fan Y; Rayet B; Gélinas C
    Oncogene; 2004 Feb; 23(5):1030-42. PubMed ID: 14647412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human RelB (I-Rel) functions as a kappa B site-dependent transactivating member of the family of Rel-related proteins.
    Bours V; Azarenko V; Dejardin E; Siebenlist U
    Oncogene; 1994 Jun; 9(6):1699-702. PubMed ID: 8183565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific inhibition of RelB/p52 transcriptional activity by the C-terminal domain of p100.
    Dobrzanski P; Ryseck RP; Bravo R
    Oncogene; 1995 Mar; 10(5):1003-7. PubMed ID: 7898917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bcl-3, a member of the I kappa B proteins, has distinct specificity towards the Rel family of proteins.
    Inoue J; Takahara T; Akizawa T; Hino O
    Oncogene; 1993 Aug; 8(8):2067-73. PubMed ID: 8336935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rel/NF-kappa B transcription factors and the control of apoptosis.
    Sonenshein GE
    Semin Cancer Biol; 1997 Apr; 8(2):113-9. PubMed ID: 9299589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A biophysical characterisation of factors controlling dimerisation and selectivity in the NF-kappaB and NFAT families.
    de Lumley M; Hart DJ; Cooper MA; Symeonides S; Blackburn JM
    J Mol Biol; 2004 Jun; 339(5):1059-75. PubMed ID: 15178248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling.
    Chen X; Kandasamy K; Srivastava RK
    Cancer Res; 2003 Mar; 63(5):1059-66. PubMed ID: 12615723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of Rel/NF-kappa B proteins in viral oncogenesis and the regulation of viral transcription.
    Mosialos G
    Semin Cancer Biol; 1997 Apr; 8(2):121-9. PubMed ID: 9299590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective activation of NF-kappa B subunits in human breast cancer: potential roles for NF-kappa B2/p52 and for Bcl-3.
    Cogswell PC; Guttridge DC; Funkhouser WK; Baldwin AS
    Oncogene; 2000 Feb; 19(9):1123-31. PubMed ID: 10713699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of DNA binding by Rel/NF-kappaB transcription factors: structural views.
    Chen FE; Ghosh G
    Oncogene; 1999 Nov; 18(49):6845-52. PubMed ID: 10602460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The Rel/NF-kappa B transcription factors and their biological functions].
    Kankova K; Vojtesek B; Valík D
    Cas Lek Cesk; 2001 Mar; 140(6):163-7. PubMed ID: 11347205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular cloning and characterization of a novel Rel/NF-kappa B family member displaying structural and functional homology to NF-kappa B p50/p105.
    Mercurio F; Didonato J; Rosette C; Karin M
    DNA Cell Biol; 1992 Sep; 11(7):523-37. PubMed ID: 1388725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct association of pp40/I kappa B beta with rel/NF-kappa B transcription factors: role of ankyrin repeats in the inhibition of DNA binding activity.
    Inoue J; Kerr LD; Rashid D; Davis N; Bose HR; Verma IM
    Proc Natl Acad Sci U S A; 1992 May; 89(10):4333-7. PubMed ID: 1533932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosomal localization of genes encoding the transcription factors, c-rel, NF-kappa Bp50, NF-kappa Bp65, and lyt-10 by fluorescence in situ hybridization.
    Mathew S; Murty VV; Dalla-Favera R; Chaganti RS
    Oncogene; 1993 Jan; 8(1):191-3. PubMed ID: 8423996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.